This is AbbVie stock's key level after upgrade, says market analyst

If AbbVie's stock can breach the $100 level, it could be off to the races, says Todd Gordon, managing director at Ascent Wealth Partners.

from Health and Science https://ift.tt/2YX7CaU
https://ift.tt/eA8V8J
https://ift.tt/2zIUzyH